Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome

Heart Rhythm

Volumn 5, Issue 4, 2008, Pages 585-590

  Patel, Chinmay ^a   Antzelevitch, Charles ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

Antiarrhythmic drugs; Arrhythmias; Electrophysiology; Inherited syndromes; Pharmacology; Sudden cardiac death

Indexed keywords

I KAPPA B KINASE INHIBITOR; PD 118057; QUINIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARRHYTHMOGENESIS; ARTICLE; CONTROLLED STUDY; DOG; ELECTROCARDIOGRAM; ENDOCARDIUM; EPICARDIUM; HEART LEFT VENTRICLE WALL; HEART MUSCLE; HEART PACING; HEART REPOLARIZATION; MEMBRANE POTENTIAL; NONHUMAN; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; QT INTERVAL; R WAVE; REFRACTORY PERIOD; SHORT QT SYNDROME; SHORT QT SYNDROME 1; T WAVE;

ACTION POTENTIALS; ANIMALS; ANTHRANILIC ACIDS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DOGS; ELECTROPHYSIOLOGY; ENDOCARDIUM; ETHER-A-GO-GO POTASSIUM CHANNELS; HEART VENTRICLES; MEMBRANE POTENTIALS; MODELS, ANIMAL; MODELS, THEORETICAL; PERICARDIUM; POTASSIUM CHANNELS; QUINIDINE; RISK FACTORS;

EID: 40849137601     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.01.022     Document Type: Article

References (24)

1. Gussak I., Brugada P., Brugada J., et al. Idiopathic short QT interval: a new clinical syndrome?. Cardiology 94 (2000) 99-102
2. Gussak I., Brugada P., Brugada J., et al. ECG phenomenon of idiopathic and paradoxical short QT intervals. Cardiac Electrophysiol Rev 6 (2002) 49-53
3. Gaita F., Giustetto C., Bianchi F., et al. Short QT syndrome: a familial cause of sudden death. Circulation 108 (2003) 965-970
4. Bjerregaard P., and Gussak I. Short QT syndrome: mechanisms, diagnosis and treatment. Nat Clin Pract Cardiovasc Med 2 (2005) 84-87
5. Gussak I., and Bjerregaard P. Short QT syndrome-5 years of progress. J Electrocardiol 38 (2005) 375-377
6. Brugada R., Hong K., Dumaine R., et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109 (2004) 30-35
7. Bellocq C., Van Ginneken A.C., Bezzina C.R., et al. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109 (2004) 2394-2397
8. Priori S.G., Pandit S.V., Rivolta I., et al. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 96 (2005) 800-807
9. Antzelevitch C., Pollevick G.D., Cordeiro J.M., et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115 (2007) 442-449
10. Giustetto C., Di Monte F., Wolpert C., et al. Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J 27 (2006) 2440-2447
11. Extramiana F., and Antzelevitch C. Amplified transmural dispersion of repolarization as the basis for arrhythmogenesis in a canine ventricular-wedge model of short QT syndrome. Circulation 110 (2004) 3661-3666
12. Milberg P., Tegelkamp R., Osada N., et al. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. J Cardiovasc Electrophysiol 18 (2007) 658-664
13. Zhou J., Augelli-Szafran C.E., Bradley J.A., et al. Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity. Mol Pharmacol 68 (2005) 876-884
14. Fish J.M., Di Diego J.M., Nesterenko V.V., et al. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: implications for biventricular pacing. Circulation 109 (2004) 2136-2142
15. Nam G.-B., Burashnikov A., and Antzelevitch C. Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia. Circulation 111 (2005) 2727-2733
16. Antzelevitch C. The role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. Am J Physiol Heart Circ Physiol 293 (2007) H2024-H2038
17. Kr inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome. Cardiovasc Res 67 (2005) 498-509
18. Medina-Ravell V.A., Lankipalli R.S., Yan G.X., et al. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization. Does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes?. Circulation 107 (2003) 740-746
19. Antzelevitch C., and Oliva A. Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes. J Intern Med 259 (2006) 48-58
20. Antzelevitch C., and Dumaine R. Electrical heterogeneity in the heart: physiological, pharmacological and clinical implications. In: Page E., Fozzard H.A., and Solaro R.J. (Eds). The Cardiovascular System. Volume 1, The Heart (2002), The American Physiological Society by Oxford University Press, New York 654-692
21. Schimpf R., Bauersfeld U., Gaita F., et al. Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis. Heart Rhythm 2 (2005) 416-417
22. Borggrefe M., Wolpert C., Antzelevitch C., et al. Short QT syndrome genotype-phenotype correlations. J Electrocardiol 38 Suppl (2005) 75-80
23. Lu L.X., Zhou W., Zhang X., et al. Short QT syndrome: a case report and review of literature. Resuscitation 71 (2006) 115-121
24. Gaita F., Giustetto C., Bianchi F., et al. Short QT syndrome: pharmacological treatment. J Am Coll Cardiol 43 (2004) 1494-1499